ARPC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.962400E-02
Normal-vs-Stage2
4.820400E-01
Normal-vs-Stage3
5.165000E-01
Normal-vs-Stage4
8.724400E-01
Stage1-vs-Stage2
9.872200E-02
Stage1-vs-Stage3
5.073400E-01
Stage1-vs-Stage4
9.977900E-02
Stage2-vs-Stage3
7.098400E-01
Stage2-vs-Stage4
5.214800E-01
Stage3-vs-Stage4
5.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.865800E-01
Normal-vs-AfricanAmerican
4.524800E-01
Normal-vs-Asian
8.071000E-01
Caucasian-vs-AfricanAmerican
9.480600E-01
Caucasian-vs-Asian
2.932400E-01
AfricanAmerican-vs-Asian
5.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.793800E-01
Normal-vs-Female
3.508400E-01
Male-vs-Female
7.664200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.103400E-01
Normal-vs-Age(41-60Yrs)
7.200400E-01
Normal-vs-Age(61-80Yrs)
3.167200E-01
Normal-vs-Age(81-100Yrs)
1.404180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.689620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.675800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.279800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.045800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.399400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.314440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.869600E-01
Normal-vs-Daily Drinker
2.501400E-01
Normal-vs-Weekly Drinker
4.476800E-01
Normal-vs-Occasional Drinker
8.774400E-01
Normal-vs-Social Drinker
3.040200E-01
Non Drinker-vs-Daily Drinker
7.988200E-01
Non Drinker-vs-Weekly Drinker
3.123800E-01
Non Drinker-vs-Occasional Drinker
4.310200E-02
Non Drinker-vs-Social Drinker
7.073400E-01
Daily Drinker-vs-Weekly Drinker
4.627600E-01
Daily Drinker-vs-Occasional Drinker
9.698300E-02
Daily Drinker-vs-Social Drinker
8.889400E-01
Weekly Drinker-vs-Occasional Drinker
3.931000E-01
Weekly Drinker-vs-Social Drinker
5.885400E-01
Occasional Drinker-vs-Social Drinker
1.762790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.425000E-01
Normal-vs-Grade 2
1.382070E-02
Normal-vs-Grade 3
3.324200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.94489999958559E-07
Grade 1-vs-Grade 3
1.188320E-04
Grade 1-vs-Grade 4
4.425000E-01
Grade 2-vs-Grade 3
9.431800E-01
Grade 2-vs-Grade 4
1.382070E-02
Grade 3-vs-Grade 4
3.324200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.335000E-01
Normal-vs-NonDiabetic
3.854400E-01
Diabetic-vs-NonDiabetic
9.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.349400E-01
Normal-vs-NoPancreatitis
4.021400E-01
Pancreatitis-vs-NoPancreatitis
1.773020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.788400E-01
Normal-vs-N1
4.430400E-01
N0-vs-N1
7.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.569000E-01
Normal-vs-TP53-NonMutant
8.644300E-02
TP53-Mutant-vs-TP53-NonMutant
2.5448999996236E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
